Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

A receptor tyrosine kinase, UFO/Axl, and other genes isolated by a modified differential display PCR are overexpressed in metastatic prostatic carcinoma cell line DU145.

Jacob AN, Kalapurakal J, Davidson WR, Kandpal G, Dunson N, Prashar Y, Kandpal RP.

Cancer Detect Prev. 1999;23(4):325-32.

PMID:
10403904
2.

Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.

Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.

Gene. 2001 Nov 14;279(1):17-31.

PMID:
11722842
3.

Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.

Chakrabarti R, Robles LD, Gibson J, Muroski M.

Cancer Genet Cytogenet. 2002 Dec;139(2):115-25.

PMID:
12550771
4.
5.

Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.

van Ginkel PR, Gee RL, Shearer RL, Subramanian L, Walker TM, Albert DM, Meisner LF, Varnum BC, Polans AS.

Cancer Res. 2004 Jan 1;64(1):128-34.

7.

Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.

Wu GJ, Varma VA, Wu MW, Wang SW, Qu P, Yang H, Petros JA, Lim SD, Amin MB.

Prostate. 2001 Sep 15;48(4):305-15.

PMID:
11536311
9.

Differential expression of the ufo/axl oncogene in human leukemia-lymphoma cell lines.

Challier C, Uphoff CC, Janssen JW, Drexler HG.

Leukemia. 1996 May;10(5):781-7.

PMID:
8656672
10.

Expression of homeobox gene-GBX2 in human prostatic cancer cells.

Gao AC, Isaacs JT.

Prostate. 1996 Dec;29(6):395-8.

PMID:
8977637
11.

Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.

Davis JN, Wojno KJ, Daignault S, Hofer MD, Kuefer R, Rubin MA, Day ML.

Cancer Res. 2006 Dec 15;66(24):11897-906.

12.
13.

Expression of tyrosine kinase gene in mouse thymic stromal cells.

Rinke de Wit TF, Izon DJ, Revilla C, Oosterwegel M, Bakker AQ, van Ewijk W, Kruisbeek AM.

Int Immunol. 1996 Nov;8(11):1787-95.

PMID:
8943574
14.

Links between Fer tyrosine kinase expression levels and prostate cell proliferation.

Allard P, Zoubeidi A, Nguyen LT, Tessier S, Tanguay S, Chevrette M, Aprikian A, Chevalier S.

Mol Cell Endocrinol. 2000 Jan 25;159(1-2):63-77.

PMID:
10687853
15.

High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets.

Müller-Tidow C, Schwäble J, Steffen B, Tidow N, Brandt B, Becker K, Schulze-Bahr E, Halfter H, Vogt U, Metzger R, Schneider PM, Büchner T, Brandts C, Berdel WE, Serve H.

Clin Cancer Res. 2004 Feb 15;10(4):1241-9.

16.

Overexpression of the EphA2 tyrosine kinase in prostate cancer.

Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ, Kinch MS.

Prostate. 1999 Dec 1;41(4):275-80.

PMID:
10544301
17.

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

Ishiguro H, Nakaigawa N, Miyoshi Y, Fujinami K, Kubota Y, Uemura H.

Prostate. 2005 Jun 15;64(1):92-100.

PMID:
15666359
18.

Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.

Cheng XF, Li D, Zhuang M, Chen ZY, Lu DX, Hattori T.

Tohoku J Exp Med. 2008 Sep;216(1):35-45.

19.

PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.

Srikantan V, Zou Z, Petrovics G, Xu L, Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino K, Buzard GS, Mostofi FK, McLeod DG, Moul JW, Srivastava S.

Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12216-21.

20.

Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer.

Müller-Tidow C, Diederichs S, Bulk E, Pohle T, Steffen B, Schwäble J, Plewka S, Thomas M, Metzger R, Schneider PM, Brandts CH, Berdel WE, Serve H.

Cancer Res. 2005 Mar 1;65(5):1778-82.

Supplemental Content

Support Center